Fertilisers & Agrochemicals · Chemicals: Agricultural · NSE: INSECTICID · data 2026-10-30
Insecticides (India) Limited
In plain words
Price: 33.0% below its 52-week high of ₹775.
Delivery: 63.1% of traded shares were kept for delivery over the last 10 sessions, against 56.8% over the last 60.
Latest results: a net profit of ₹44 cr for the quarter ended Jun 2026 (-24.5% on the same quarter a year earlier).
A description of the data, not a recommendation.
Key figures
Growth
| Revenue (last 12 months) | ₹2,060 cr |
| Net profit (last 12 months) | ₹125 cr |
| Sales growth, 3 years (yearly) | 6.0% |
| Profit growth, 3 years (yearly) | 30.2% |
Latest results in brief (Q1 FY27)
INSECTICID Q1 FY27 results (consolidated figures, as filed on NSE).
Revenue was ₹611.52 crore, down 11.5% YoY and up 43.5% QoQ.
Net profit was ₹43.87 crore, down 24.5% YoY and up 274.6% QoQ.
Operating margin was 11.1% (12.2% a year ago).
EPS was ₹15.08, down 24.5% YoY and up 275.1% QoQ.
INSECTICID के Q1 FY27 नतीजे (कंसोलिडेटेड आंकड़े, NSE पर दाखिल)।
राजस्व: ₹611.52 करोड़; पिछले साल की तुलना में 11.5% की गिरावट, पिछली तिमाही की तुलना में 43.5% की बढ़त।
शुद्ध मुनाफ़ा: ₹43.87 करोड़; पिछले साल की तुलना में 24.5% की गिरावट, पिछली तिमाही की तुलना में 274.6% की बढ़त।
ऑपरेटिंग मार्जिन: 11.1% (एक साल पहले 12.2%)।
EPS: ₹15.08; पिछले साल की तुलना में 24.5% की गिरावट, पिछली तिमाही की तुलना में 275.1% की बढ़त।
INSECTICIDના Q1 FY27 પરિણામો (કન્સોલિડેટેડ આંકડા, NSE પર ફાઇલ કરેલા).
આવક (રેવન્યુ): ₹611.52 કરોડ; ગયા વર્ષની સરખામણીએ 11.5% ઘટાડો, ગયા ક્વાર્ટરની સરખામણીએ 43.5% વધારો.
ચોખ્ખો નફો: ₹43.87 કરોડ; ગયા વર્ષની સરખામણીએ 24.5% ઘટાડો, ગયા ક્વાર્ટરની સરખામણીએ 274.6% વધારો.
ઓપરેટિંગ માર્જિન: 11.1% (એક વર્ષ પહેલાં 12.2%).
EPS: ₹15.08; ગયા વર્ષની સરખામણીએ 24.5% ઘટાડો, ગયા ક્વાર્ટરની સરખામણીએ 275.1% વધારો.
Written from the filed numbers. Not a recommendation.
Smart-money activity
12/100 · Weak over the last ~60 sessions, data 2026-10-30
- Delivery vs usual 7/30: Delivery 60.5% over the last 20 sessions vs 49.5% in the 40 before (1.22x); shares delivered per day 0.4x usual; 0 delivery-spike days (3x usual shares delivered, 40%+ delivery) in the last 20 sessions.
- Bulk/block deals 0/20: No bulk or block deals in the last 90 days.
- Insider / SAST buys 0/15: No insider buy or SAST acquisition filings in the last 90 days. Insider sells are not collected by the site, so only buy filings count.
- Mutual fund holding 0/15: No mutual fund scheme lists this stock. Latest monthly portfolios only (top 60 holdings per scheme); month-on-month change is not stored.
- Accumulation evidence 0/15: No accumulation evidence row (only saved-scan stocks have one; 0 points).
- Promoter pledges 5/5: No promoter pledge filings in 90 days.
A description of recorded activity (delivery, deals, insider buys, fund holding, pledges), not a recommendation. Today's most active stocks.
Story so far
● Results ● Dividend
- 11 Aug 26Results Q1 FY27 results: profit −24.5% YoY -3.3% next session
- 28 May 26Results Q4 FY26 results: profit −15.7% YoY -3.9% next session
- 6 Feb 26Dividend Dividend ₹2 (ex-date) +4.5% next session
- 30 Jan 26Results Q3 FY26 results: profit −39.6% YoY -5.6% next session
- 12 Nov 25Results Q2 FY26 results: profit −3.9% YoY -2.4% next session
- 13 Aug 25Results Q1 FY26 results: profit +18.6% YoY -16.0% next session
- 28 May 25Results Q4 FY25 results: profit +79.0% YoY +5.4% next session
- 10 Feb 25Results Q3 FY25 results: profit +41.0% YoY -7.3% next session
- 11 Nov 24Results Q2 FY25 results: profit +15.7% YoY -12.5% next session
From official exchange filings and NSE data. How the price moved after an event describes the past, not what comes next.
Quarterly results (consolidated)
| Quarter | Revenue | Net profit | Profit YoY | Op. margin | EPS ₹ |
|---|---|---|---|---|---|
| Jun 2026 | ₹612 cr | ₹44 cr | -24.5% | 11.1% | 15.08 |
| Mar 2026 | ₹426 cr | ₹12 cr | -15.7% | 6.0% | 4.02 |
| Dec 2025 | ₹385 cr | ₹10 cr | -39.6% | 7.1% | 3.6 |
| Sept 2025 | ₹638 cr | ₹59 cr | -3.9% | 14.0% | 20.31 |
Shareholding trend
| Holder | Sept 2026 | Jun 2026 | Mar 2026 | Dec 2025 |
|---|---|---|---|---|
| Promoters | 72.30% | 72.30% | 72.30% | 72.30% |
| Foreign institutions (FII) | 4.44% | 4.40% | 4.50% | 4.46% |
| Domestic institutions (DII) | 9.26% | 9.26% | 9.27% | 9.40% |
| Mutual funds | 8.93% | 8.93% | 8.93% | 9.06% |
| Retail investors | 8.89% | 9.23% | 9.65% | 9.61% |
| Number of shareholders | 19,691 | 21,380 | 22,274 | 22,359 |
Common questions
What was Insecticides (India) Limited's latest quarterly profit?
Insecticides (India) Limited reported a net profit of ₹44 cr for the quarter ended Jun 2026 (-24.5% on the same quarter a year earlier), on revenue of ₹612 cr.
How much do promoters hold in Insecticides (India) Limited?
Promoters held 72.30% of Insecticides (India) Limited at the end of Sept 2026, with 0.00% of promoter shares pledged.
Is Insecticides (India) Limited debt-free?
Its latest reported debt-to-equity ratio is 0.13.
What is Insecticides (India) Limited's P/E ratio?
About 12.1, based on the last 12 months' earnings and a price of ₹519.2 (data 2026-10-30).
What is the 52-week high and low of Insecticides (India) Limited?
The 52-week high is ₹775 and the 52-week low is ₹500.
Similar companies
Bharat Rasayan Limited (BHARATRAS) · India Pesticides Ltd. (IPL) · Astec Lifesciences Limited (ASTEC) · Punjab Chemicals & Crop Protection Ltd. (PUNJABCHEM) · Kothari Industrial Corp. Ltd. (KOTIC)
The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.
Open INSECTICID in NSE Scanner →